Cite
HARVARD Citation
Virk, H. et al. (n.d.). The utility of fluorescence in situ hybridization testing in patients clinically suspected of myelodysplastic syndrome or myelodysplastic syndrome/myeloproliferative neoplasm overlap is limited in the absence of significant morphological dysplasia. International journal of laboratory hematology. pp. e287-e290. [Online].